Interviews from the 33rd SICOB National Congress
The Scourge of Obesity: Between Surgery and New Drugs
Interviews from the 33rd SICOB National Congress
The Scourge of Obesity: Between Surgery and New Drugs
The national event of the Italian Society of Obesity and Metabolic Disease Surgery highlights the main scientific and clinical advances in obesity treatment: metabolic surgery, new drugs, multidisciplinary approaches, and digital technologies. Experts discuss effective strategies to combat one of the most serious contemporary health emergencies.
The national event of the Italian Society of Obesity and Metabolic Disease Surgery highlights the main scientific and clinical advances in obesity treatment: metabolic surgery, new drugs, multidisciplinary approaches, and digital technologies. Experts discuss effective strategies to combat one of the most serious contemporary health emergencies.
Multimodal treatment of obesity to counter therapeutic inertia
it
Dr. Maurizio De Luca
SICOB guidelines recommendations on surgical and endoscopic treatments
it
Prof. Giuseppe Navarra
Symbiosis between bariatric surgery and anti-obesity drugs: what are the benefits for patients?
it
Prof. Marco A. Zappa
Careful selection of the obese patient before any therapeutic choice
it
Prof. Monica Nannipieri
Swallowable balloon + GLP-1 agonists: efficacy of combination therapy against obesity
it
Dr. Luigi Flagiello
Obese young people: quickly recognize the stage of the disease
it
Prof. Luigi Angrisani
A multidisciplinary approach to obesity: what are the benefits for the patient?
it
Prof. Carlo De Werra
Obesity: A multimodal approach to addressing relapses
it
Dr. Gianluca Rossetti